Clinical Trial Update: Exchangeable and Relative Exchangeable Copper as an Alternative to 24-Hour Urinary Copper in Wilson's Disease Monitoring

View source ↗

Summary

A completed clinical trial evaluates exchangeable and relative exchangeable copper as alternatives to 24-hour urinary copper for monitoring Wilson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Snippet

Sponsor: Hacettepe University | Conditions: Wilson's Disease | Status: COMPLETED